Perforin inhibition significantly reversed both baseline and AZD1775-enhanced KIL control of MOC2 tumor cells (Fig. 5a), suggesting that AZD1775 enhanced granzyme B-dependent control of MOC2. The gene discussed is GZMB; the disease is neoplasm.